CYTOVAC A/S: Financial statements 2013
CVR: 31262666
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -6,550,897 and a net result of DKK -10,883,498 compared with DKK -10,927,052 the year before. Equity in the 2013 report amounted to DKK 1,946,781. The solvency ratio was 6.7%.
- Gross Profit
- DKK -6,550,897
- Profit/Loss
- DKK -10,883,498
- Equity
- DKK 1,946,781
- Total Assets
- DKK 29,033,276
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -6.6M | -10.9M | 1.9M | - |
| 2012 | - | -5.2M | -10.9M | 12.8M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
CYTOVAC A/S has published its annual report for 2012. Gross profit came to DKK -5,240,827, and the net result was DKK -10,927,052.
As of May 30, 2013, Hans Christian Petersen has left the board of directors of CYTOVAC A/S.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.